Clinical Trials Enrolling Participants

Study of CD19-targeted NEX-T CAR T Cells in Participants with Relapsing Forms of Multiple Sclerosis (RMS) or Progressive Forms of Multiple Sclerosis (PMS)

TILS-021 Study for Secondary Progressive MS

Efficacy and safety study of frexalimab (SAR441344) in adults with nonrelapsing secondary progressive Multiple Sclerosis

Identifying and Characterizing Preclinical MS

Neurology Data Registry & Biorepository

Intestinal Immunity in Neurologic Disease

AMS05: Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis

Central Vein Sign: a Diagnostic Biomarker in Multiple Sclerosis